Removal of the DATA Waiver requirements needed to expand access to medications for opioid use disorder

BCHC provided comments to SAMHSA about the proposed rule on Medications for the Treatment of Opioid Use Disorder: Removal of the DATA-2000 Waiver Requirements. Comments include how the removal would benefit people diagnosed with an opioid use disorder as well as broaden access to treatment and increase patient safety.